Orphanet

Orphanet
Name	Orphanet
Formation	1997
Type	International network
Purpose	Information on rare diseases and orphan drugs
Headquarters	Paris, France
Region served	Europe and beyond

Orphanet is an international reference portal providing information on rare diseases, orphan drugs, and related resources. Established in the late 1990s, it aggregates clinical, genetic, and bibliographic data to support clinicians, researchers, patients, and policy makers. It operates through a network of national teams and expert contributors to maintain a multilingual, codified resource used across health systems.

History

Orphanet originated from initiatives in the 1990s to address gaps highlighted by stakeholders such as the European Commission, World Health Organization, Institut Pasteur, National Institute for Health and Care Excellence, and patient advocacy groups like EURORDIS. Early development involved collaborations with institutional contributors including INSERM, CNRS, Université Paris Cité, and the European Medicines Agency. Over time, Orphanet integrated standards from nomenclature efforts such as OMIM, ICD-10, SNOMED CT, and linked to resources maintained by UniProt, PubMed, ClinVar, and national registries in countries like France, Spain, Italy, and Germany. Major milestones paralleled policy advances such as the Orphan Drug Act in the United States and the Regulation (EC) No 141/2000 in the European Union.

Organization and Governance

The networked governance model includes contributions from academic institutions exemplified by Université de Lorraine, Université Paris Cité, and research bodies like INSERM and CNRS. National teams coordinate with healthcare entities such as Assistance Publique–Hôpitaux de Paris and specialty centers including Great Ormond Street Hospital for pediatrics. Advisory input has come from experts affiliated with universities including Harvard University, University of Oxford, Karolinska Institutet, and University of Milan. Funding and oversight interfaces involve agencies like the European Commission, national health ministries in Belgium and Portugal, and philanthropic organizations such as the Wellcome Trust and Bill & Melinda Gates Foundation in collaborative contexts.

Database and Services

Orphanet provides structured entries linking to terminologies and databases like OMIM, Orphan Drug Act registry, ClinicalTrials.gov, European Medicines Agency, EudraCT, PubMed Central, and protein/gene resources such as Ensembl and UniProt. Service features include a searchable rare disease nomenclature, inventory of expert centers comparable to listings from Centers for Disease Control and Prevention, catalogs of patient organizations akin to networks like Rare Diseases International, and listings of orphan medicinal products aligned with approvals by agencies including European Medicines Agency and Food and Drug Administration. Additional services mirror tools used by Genomics England and UK Biobank for linking phenotypes and genotypes across registries and biobanks.

Coverage and Content

Content spans clinical descriptions, epidemiology, inheritance patterns, diagnostic tests, management advice, and bibliographies referencing publishers and databases such as Nature Publishing Group, Elsevier, Wiley, The Lancet, New England Journal of Medicine, and indexing in PubMed. Disease entries cross-reference classifications like ICD-10, gene symbols curated at HGNC, and variant annotations from ClinVar. The resource collates links to patient advocacy organizations comparable to EURORDIS, national rare disease centers in Spain and Poland, and research consortia such as International Rare Diseases Research Consortium.

Collaborations and Partnerships

Orphanet partners with international and national bodies including the European Commission, World Health Organization, European Medicines Agency, and university hospitals such as Hospital Clínic de Barcelona and Karolinska University Hospital. Research collaborations link to consortia like IRDiRC and initiatives such as Horizon 2020 and IMI. It exchanges data and standards with nomenclature and bioinformatics providers including HGNC, OMIM, Ensembl, and ClinVar's contributors, and aligns with registries like European Cystic Fibrosis Society Patient Registry and national rare disease registries across United Kingdom, France, and Germany.

Impact and Usage

Orphanet is cited by clinical guideline developers such as NICE, research funders including Horizon Europe, and patient advocacy groups like EURORDIS and Rare Voices Australia. Its data inform regulatory assessments at the European Medicines Agency and national health technology assessment processes in France and Italy. Academic use spans institutions like Harvard Medical School, University of Oxford, Karolinska Institutet, and publications in journals including The Lancet and Nature Genetics. Health information systems and electronic health record initiatives in countries such as France and Portugal integrate Orphanet identifiers for interoperability.

Accessibility and Funding

Orphanet operates as a multilingual platform with interfaces and outputs used across Europe and globally, aligning with open data practices advocated by organizations such as the European Open Science Cloud and OpenAIRE. Funding model draws from a mix of public grants provided by the European Commission, national health agencies in France and Belgium, research funding from programs like Horizon 2020 and philanthropic contributions from entities such as the Wellcome Trust. Accessibility efforts coordinate with patient groups including EURORDIS and healthcare providers at institutions like Great Ormond Street Hospital to ensure usability for clinicians, researchers, and patients.

Category:Medical databases